ArticleImmunoTargets and therapy2024

Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis.

Wen-Bin Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.